Inverse relation between nasal fluid Clara Cell Protein 16 levels and symptoms and signs of rhinitis in allergen-challenged patients with intermittent allergic rhinitis

被引:34
作者
Benson, M. [1 ]
Fransson, M.
Martinsson, T.
Naluai, A. T.
Uddman, R.
Cardell, L. O.
机构
[1] Queen Silvia Childrens Hosp, SE-41685 Gothenburg, Sweden
[2] Malmo Univ Hosp, Dept Otorhinolaryngol, Lab Clin & Expt Allergy Res, Malmo, Sweden
[3] Dept Clin Genet, Gothenburg, Sweden
关键词
allergic rhinitis; Clara Cell Protein 16; nasal fluid;
D O I
10.1111/j.1398-9995.2006.01264.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Decreased levels of the anti-inflammatory Clara Cell Protein 16 (CC16) are found in intermittent allergic rhinitis (IAR) and asthma. In asthma this decrease has been associated with hyperreactivity and the A38G single nucleotide polymorphism (SNP). The aim of this study was to examine if IAR is associated with signs and symptoms of rhinitis and the A38G SNP. Nasal fluid CC16 was analyzed in 20 patients with IAR before allergen challenge and 1 and 6 h after challenge, and from 28 healthy controls. The A38G SNP was analyzed in 80 patients with IAR and 106 controls. Nasal biopsies were obtained from three subjects in each group for immunohistochemical analysis of CC16. In the allergen-challenged patients symptoms and rhinoscopic signs of rhinitis increased after 1 h and normalized after 6 h. In contrast, nasal fluid CC16 decreased 1 h after allergen challenge and returned to baseline after 6 h. Nasal fluid CC16 levels did not differ from controls before and 6 h after challenge. Immunohistochemical investigation showed intense CC16 staining in the nasal epithelium of both patients before season and healthy controls, but weak staining in symptomatic patients during season. No significant association between the A38G SNP and IAR was found. There was an inverse relation between nasal fluid CC16 levels and symptoms and signs of rhinitis in allergen-challenged patients with IAR. However, there was no association between IAR and the A38G SNP.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 25 条
[1]   Gene profiling reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis [J].
Benson, M ;
Jansson, L ;
Adner, M ;
Luts, A ;
Uddman, R ;
Cardell, LO .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (04) :473-478
[2]   Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps [J].
Benson, M ;
Carlsson, L ;
Adner, M ;
Jernås, M ;
Rudemo, M ;
Sjögren, A ;
Svensson, PA ;
Uddman, R ;
Cardell, LO .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (06) :1137-1143
[3]   DNA microarray analysis of transforming growth factor-β and related transcripts in nasal biopsies from patients with allergic rhinitis [J].
Benson, M ;
Carlsson, B ;
Carlsson, LMS ;
Mostad, P ;
Svensson, PA ;
Cardell, LO .
CYTOKINE, 2002, 18 (01) :20-25
[4]   Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-γ, IL-1β,TNF-α, or neutrophils [J].
Benson, M ;
Strannegård, IL ;
Strannegård, Ö ;
Wennergren, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (02) :307-312
[5]  
BERNARD A, 1992, EUR RESPIR J, V5, P1231
[6]   Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes [J].
Candelaria, PV ;
Backer, V ;
Laing, IA ;
Porsbjerg, C ;
Nepper-Christensen, S ;
de Klerk, N ;
Goldblatt, J ;
Le Souëf, PN .
IMMUNOGENETICS, 2005, 57 (1-2) :25-32
[7]  
Cowan MJ, 2000, ANN NY ACAD SCI, V923, P193
[8]   A role for neutrophils in intermittent allergic rhinitis [J].
Fransson, M ;
Benson, M ;
Wennergren, G ;
Cardell, LO .
ACTA OTO-LARYNGOLOGICA, 2004, 124 (05) :616-620
[9]   Pseudomonas aeruginosa and tumor necrosis factor-α attenuate Clara cell secretory protein promoter function [J].
Harrod, KS ;
Jaramillo, RJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (02) :216-223
[10]   A revised nomenclature for allergy -: An EAACI position statement from the EAACI nomenclature task force [J].
Johansson, SGO ;
Hourihane, JO ;
Bousquet, J ;
Bruijnzeel-Koomen, C ;
Dreborg, S ;
Haahtela, T ;
Kowalski, ML ;
Mygind, N ;
Ring, J ;
van Cauwenberge, P ;
van Hage-Hamsten, M ;
Wüthrich, B .
ALLERGY, 2001, 56 (09) :813-824